Development of Composition and Technology of Resveratrol Capsules

Introduction. Resveratrol is of scientific interest as a substance with a wide range of biological effects. However, its low bioavailability leads to limited use when administered orally. Therefore, the objective was to increase its solubility using various groups of excipients and create a solid do...

Full description

Saved in:
Bibliographic Details
Main Authors: M. S. Sokurenko, S. P. Krechetov, S. A. Olifer, I. I. Krasnyuk, N. L. Solovyova, M. A. Makarenko, N. B. Demina
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-11-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/733
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850047045811830784
author M. S. Sokurenko
S. P. Krechetov
S. A. Olifer
I. I. Krasnyuk
N. L. Solovyova
M. A. Makarenko
N. B. Demina
author_facet M. S. Sokurenko
S. P. Krechetov
S. A. Olifer
I. I. Krasnyuk
N. L. Solovyova
M. A. Makarenko
N. B. Demina
author_sort M. S. Sokurenko
collection DOAJ
description Introduction. Resveratrol is of scientific interest as a substance with a wide range of biological effects. However, its low bioavailability leads to limited use when administered orally. Therefore, the objective was to increase its solubility using various groups of excipients and create a solid dosage form. As a result of research, a group of twins was selected and the technology of manufacturing capsules containing 40 mg of resveratrol as a active substance was developed.Aim. The development of a solid dosage form – capsules containing resveratrol, tween 80 as a solubilizer and other excipients.Materials and methods. A composition with resveratrol, tween 80, glycerin, citric and ascorbic acids as stabilizers was developed. Methanol was used as a common solvent and was distilled off after complete dissolution of all components and obtaining a homogeneous mass. After adding olive oil (as a filler) to the resulting composition and a mixture of nipazole and nipagin (0.03 % by weight of the contents), the composition was manually mixed and poured into subsequently gelatin coated capsules for tightness. The quality indicators of the obtained capsules were studied in accordance with the requirements of the State pharmacopoeia XIV of Russian Federation (description, disintegration, dissolution, uniformity of dosage, residual organic solvents), as well as oxidation indicators.Results and discussion. During the research it was found that the obtained samples of capsules containing resveratrol 40 mg/caps. as an active substance, and tween 80 as a solubilizer, had a good disintegration. The substance is well soluble in hydrochloric acid condition, which indicates its high bioavailability.Conclusion. To produce capsules with resveratrol (40 mg/caps.) containing tween 80, glycerin, citric and ascorbic acids, excipients were selected according to studies that confirm the improvement of resveratrol bioavailability. The quality of the dosage form was assessed in accordance with the State Pharmacopoeia XIVth edition: it was shown that the use of Tween 80 as a solubilizer increases the release of resveratrol in the environment of gastric juice.
format Article
id doaj-art-587820996d1148e28423c1909d9b2570
institution DOAJ
issn 2305-2066
2658-5049
language Russian
publishDate 2019-11-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj-art-587820996d1148e28423c1909d9b25702025-08-20T02:54:18ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492019-11-0184161910.33380/2305-2066-2019-8-4-16-19704Development of Composition and Technology of Resveratrol CapsulesM. S. Sokurenko0S. P. Krechetov1S. A. Olifer2I. I. Krasnyuk3N. L. Solovyova4M. A. Makarenko5N. B. Demina6Scientific Research Institute of NutritionMoscow Institute of Physics and Technology, MIPTI. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)Scientific Research Institute of NutritionI. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)Introduction. Resveratrol is of scientific interest as a substance with a wide range of biological effects. However, its low bioavailability leads to limited use when administered orally. Therefore, the objective was to increase its solubility using various groups of excipients and create a solid dosage form. As a result of research, a group of twins was selected and the technology of manufacturing capsules containing 40 mg of resveratrol as a active substance was developed.Aim. The development of a solid dosage form – capsules containing resveratrol, tween 80 as a solubilizer and other excipients.Materials and methods. A composition with resveratrol, tween 80, glycerin, citric and ascorbic acids as stabilizers was developed. Methanol was used as a common solvent and was distilled off after complete dissolution of all components and obtaining a homogeneous mass. After adding olive oil (as a filler) to the resulting composition and a mixture of nipazole and nipagin (0.03 % by weight of the contents), the composition was manually mixed and poured into subsequently gelatin coated capsules for tightness. The quality indicators of the obtained capsules were studied in accordance with the requirements of the State pharmacopoeia XIV of Russian Federation (description, disintegration, dissolution, uniformity of dosage, residual organic solvents), as well as oxidation indicators.Results and discussion. During the research it was found that the obtained samples of capsules containing resveratrol 40 mg/caps. as an active substance, and tween 80 as a solubilizer, had a good disintegration. The substance is well soluble in hydrochloric acid condition, which indicates its high bioavailability.Conclusion. To produce capsules with resveratrol (40 mg/caps.) containing tween 80, glycerin, citric and ascorbic acids, excipients were selected according to studies that confirm the improvement of resveratrol bioavailability. The quality of the dosage form was assessed in accordance with the State Pharmacopoeia XIVth edition: it was shown that the use of Tween 80 as a solubilizer increases the release of resveratrol in the environment of gastric juice.https://www.pharmjournal.ru/jour/article/view/733bioavailabilitypolyphenolic compoundsantioxidantsresveratroltween 80
spellingShingle M. S. Sokurenko
S. P. Krechetov
S. A. Olifer
I. I. Krasnyuk
N. L. Solovyova
M. A. Makarenko
N. B. Demina
Development of Composition and Technology of Resveratrol Capsules
Разработка и регистрация лекарственных средств
bioavailability
polyphenolic compounds
antioxidants
resveratrol
tween 80
title Development of Composition and Technology of Resveratrol Capsules
title_full Development of Composition and Technology of Resveratrol Capsules
title_fullStr Development of Composition and Technology of Resveratrol Capsules
title_full_unstemmed Development of Composition and Technology of Resveratrol Capsules
title_short Development of Composition and Technology of Resveratrol Capsules
title_sort development of composition and technology of resveratrol capsules
topic bioavailability
polyphenolic compounds
antioxidants
resveratrol
tween 80
url https://www.pharmjournal.ru/jour/article/view/733
work_keys_str_mv AT mssokurenko developmentofcompositionandtechnologyofresveratrolcapsules
AT spkrechetov developmentofcompositionandtechnologyofresveratrolcapsules
AT saolifer developmentofcompositionandtechnologyofresveratrolcapsules
AT iikrasnyuk developmentofcompositionandtechnologyofresveratrolcapsules
AT nlsolovyova developmentofcompositionandtechnologyofresveratrolcapsules
AT mamakarenko developmentofcompositionandtechnologyofresveratrolcapsules
AT nbdemina developmentofcompositionandtechnologyofresveratrolcapsules